(Q41760509)
Statements
1 reference
Phase 1 trial of a single dose of recombinant human interleukin-12 in human immunodeficiency virus-infected patients with 100-500 CD4 cells/microL. (English)
1 reference
Jacobson MA
1 reference
Hardy D
1 reference
Connick E
1 reference
Watson J
1 reference
DeBruin M
1 reference
28 August 2000
1 reference
1 reference
182
1 reference
4
1 reference
1070-1076
1 reference